Dextera Surgical Inc. (fka DXTRQ)

[yesterdaysnews74]

The $.80 pps placed here earlier and Zacks hold with the 1.67 brokers recommendation, makes $.20 - $.40 a worthwhile risk.

My belief is that the misses on the last two estimates will drive a super low estimate for 4th quarter, and pending a few moves DXTR is projected to make and assistance in production and shipping, they'll kill the estimate driving the pps well over $1 right before delisting, which then we will possibly see the RS to make the pps and merge/bo talks worth much more.

Final estimates if all this were to take place is a pps around $8 - $10. Right on target for a pharmaceutical supply company.